{
    "2020-03-04": [
        [
            {
                "time": "2023-10-18",
                "original_text": "Nearly $300M, six CEOs and dead-ends later, East Bay drugmaker gets date with FDA for migraine treatment",
                "features": {
                    "keywords": [
                        "FDA",
                        "migraine treatment",
                        "drugmaker",
                        "East Bay",
                        "dead-ends"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}